Author Topic: New inroads against MS [JAMA interview with Dr. Stephen Hauser and Dr. Jeffrey Cohen]  (Read 47 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest
JAMA interview (December 13, 2017) with Dr. Stephen Hauser and Dr. Jeffrey A. Cohen. Stephen Hauser, MD, of the University of California, San Francisco, led the development of ocrelizumab, and Jeffrey A. Cohen, MD, of the Cleveland Clinic,  has been pursuing research into remyelination.

The focus of the discussion is on Ocrevus:

https://jamanetwork.com/journals/jama/fullarticle/2666528
MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
52 Views
Last post May 16, 2016, 03:54:29 pm
by agate
0 Replies
35 Views
Last post November 15, 2016, 04:25:12 pm
by agate
0 Replies
71 Views
Last post December 19, 2016, 08:04:13 am
by agate
0 Replies
64 Views
Last post March 20, 2017, 07:41:32 pm
by agate
0 Replies
33 Views
Last post December 14, 2017, 04:28:42 pm
by agate